Download
s12871-021-01328-3.pdf 1,30MB
WeightNameValue
1000 Titel
  • Malignant hyperthermia when dantrolene is not readily available
1000 Autor/in
  1. Gong, Xiaodan |
1000 Erscheinungsjahr 2021
1000 Publikationstyp
  1. Artikel |
1000 Online veröffentlicht
  • 2021-04-16
1000 Erschienen in
1000 Quellenangabe
  • 21(1):119
1000 Copyrightjahr
  • 2021
1000 Lizenz
1000 Verlagsversion
  • https://doi.org/10.1186/s12871-021-01328-3 |
  • https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8051048/ |
1000 Publikationsstatus
1000 Sprache der Publikation
1000 Abstract/Summary
  • Background!#!Malignant hyperthermia is a rare but life-threatening pharmacogenetic muscle disorder characterized by abnormal hypermetabolic reactions and commonly triggered in susceptible individuals by volatile anesthetics or succinylcholine, or both. Unfortunately, the specific medicine dantrolene is not readily available in many countries including China. The aim of this study was to find the characteristics of malignant hyperthermia under the situation that dantrolene is not readily available.!##!Methods!#!The cases of malignant hyperthermia reported on the most commonly used databases in China from 1985 to 2020 were analyzed. The inclusion criteria were the MH episodes only related to anesthesia. The exclusion criteria were dubious MH episodes only caused by Ketamine administration or MH episodes irrelevant to anesthesia. Independent samples t-test and Pearson's chi-squared test were applied to assess the difference between the survived and death cases.!##!Results!#!Ninety-two cases of malignant hyperthermia reported on the most commonly used databases in China from 1985 to 2020 were analyzed. Median (IQR [range]) age was 18.5 (11.8-37.0 [0-70.0]) years. Compared with the survived cases, the death cases had higher maximum end-tidal partial pressure of CO!##!Conclusions!#!In countries that dantrolene is not readily available, early warning, diagnosis, and prompt effective therapies are crucial for MH patients to survive.
1000 Sacherschließung
lokal Infant, Newborn [MeSH]
lokal Blood Coagulation Disorders/epidemiology [MeSH]
lokal Malignant hyperthermia
lokal Muscle Relaxants, Central/supply
lokal Enzyme
lokal Aged [MeSH]
lokal China/epidemiology [MeSH]
lokal Tidal Volume [MeSH]
lokal Databases, Factual [MeSH]
lokal Infant [MeSH]
lokal Mortality
lokal Male [MeSH]
lokal Creatine Kinase, MB Form/blood [MeSH]
lokal Treatment
lokal Carbon Dioxide/metabolism [MeSH]
lokal Child [MeSH]
lokal Research Article
lokal Adolescent [MeSH]
lokal Female [MeSH]
lokal Myoglobin/blood [MeSH]
lokal Potassium/blood [MeSH]
lokal Adult [MeSH]
lokal Humans [MeSH]
lokal Creatine Kinase/blood [MeSH]
lokal Middle Aged [MeSH]
lokal Dantrolene/supply
lokal Malignant Hyperthermia/epidemiology [MeSH]
lokal Hydrogen-Ion Concentration [MeSH]
lokal Dantrolene
lokal Young Adult [MeSH]
lokal Arterial Pressure [MeSH]
lokal Child, Preschool [MeSH]
1000 Liste der Beteiligten
  1. https://frl.publisso.de/adhoc/uri/R29uZywgWGlhb2Rhbg==
1000 Hinweis
  • DeepGreen-ID: d0c5880e6149458da11ab4b6c824f4cc ; metadata provieded by: DeepGreen (https://www.oa-deepgreen.de/api/v1/), LIVIVO search scope life sciences (http://z3950.zbmed.de:6210/livivo), Crossref Unified Resource API (https://api.crossref.org/swagger-ui/index.html), to.science.api (https://frl.publisso.de/), ZDB JSON-API (beta) (https://zeitschriftendatenbank.de/api/), lobid - Dateninfrastruktur für Bibliotheken (https://lobid.org/resources/search)
1000 Label
1000 Dateien
  1. Malignant hyperthermia when dantrolene is not readily available
1000 Objektart article
1000 Beschrieben durch
1000 @id frl:6465171.rdf
1000 Erstellt am 2023-11-16T10:39:17.028+0100
1000 Erstellt von 322
1000 beschreibt frl:6465171
1000 Zuletzt bearbeitet 2023-12-01T01:44:47.050+0100
1000 Objekt bearb. Fri Dec 01 01:44:47 CET 2023
1000 Vgl. frl:6465171
1000 Oai Id
  1. oai:frl.publisso.de:frl:6465171 |
1000 Sichtbarkeit Metadaten public
1000 Sichtbarkeit Daten public
1000 Gegenstand von

View source